BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 33036701)

  • 1. Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study).
    Giudici KV; de Souto Barreto P; Beard J; Cantet C; Araujo de Carvalho I; Rolland Y; Vellas B;
    Maturitas; 2020 Nov; 141():39-45. PubMed ID: 33036701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
    Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT).
    Rolland Y; Barreto PS; Maltais M; Guyonnet S; Cantet C; Andrieu S; Vellas B
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of multidomain lifestyle intervention, omega-3 supplementation or their combination on physical activity levels in older adults: secondary analysis of the Multidomain Alzheimer Preventive Trial (MAPT) randomised controlled trial.
    Barreto PS; Rolland Y; Cesari M; Dupuy C; Andrieu S; Vellas B;
    Age Ageing; 2018 Mar; 47(2):281-288. PubMed ID: 29136094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of 3-Year Multidomain Intervention and Omega-3 Supplementation with Frailty Incidence.
    Guerville F; de Souto Barreto P; Giudici KV; Rolland Y; Vellas B;
    J Am Geriatr Soc; 2019 Aug; 67(8):1700-1706. PubMed ID: 31169912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Multidomain Intervention, Omega-3 Polyunsaturated Fatty Acids Supplementation or their Combinaison on Cognitive Function in Non-Demented Older Adults According to Frail Status: Results from the MAPT Study.
    Tabue-Teguo M; Barreto de Souza P; Cantet C; Andrieu S; Simo N; Fougère B; Dartigues JF; Vellas B
    J Nutr Health Aging; 2018; 22(8):923-927. PubMed ID: 30272094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of C-reactive protein and homocysteine concentrations with the impairment of intrinsic capacity domains over a 5-year follow-up among community-dwelling older adults at risk of cognitive decline (MAPT Study).
    Giudici KV; de Souto Barreto P; Guerville F; Beard J; Araujo de Carvalho I; Andrieu S; Rolland Y; Vellas B;
    Exp Gerontol; 2019 Nov; 127():110716. PubMed ID: 31493520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trial.
    Maltais M; de Souto Barreto P; Pothier K; Cantet C; Andrieu S; Rolland Y; Vellas B;
    Exp Gerontol; 2019 Jun; 120():28-34. PubMed ID: 30817982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Baseline Intrinsic Capacity and its Subdomains on the Overall Efficacy of Multidomain Intervention in Promoting Healthy Aging among Community-Dwelling Older Adults: Analysis from a Nationwide Cluster-Randomized Controlled Trial.
    Liang CK; Lee WJ; Chou MY; Hwang AC; Lin CS; Peng LN; Hsiao FY; Loh CH; Chen LK
    J Prev Alzheimers Dis; 2024; 11(2):356-365. PubMed ID: 38374742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial.
    Delrieu J; Vellas B; Guyonnet S; Cantet C; Ovod V; Li Y; Bollinger J; Bateman R; Andrieu S;
    Alzheimers Res Ther; 2023 Oct; 15(1):183. PubMed ID: 37872582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT).
    Costa N; Mounié M; Pagès A; Derumeaux H; Rapp T; Guyonnet S; Coley N; Cantet C; Carrié I; Andrieu S; Molinier L
    J Prev Alzheimers Dis; 2021; 8(4):425-435. PubMed ID: 34585216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical β-Amyloid in Older Adults Is Associated with Multidomain Interventions with and without Omega 3 Polyunsaturated Fatty Acid Supplementation.
    Hooper C; Coley N; De Souto Barreto P; Payoux P; Salabert AS; Andrieu S; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2020; 7(2):128-134. PubMed ID: 32236402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status.
    Delrieu J; Payoux P; Carrié I; Cantet C; Weiner M; Vellas B; Andrieu S
    Alzheimers Dement; 2019 Nov; 15(11):1392-1401. PubMed ID: 31558366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial.
    Moran C; Scotto di Palumbo A; Bramham J; Moran A; Rooney B; De Vito G; Egan B
    J Prev Alzheimers Dis; 2018; 5(3):175-183. PubMed ID: 29972210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA.
    Vellas B; Carrie I; Gillette-Guyonnet S; Touchon J; Dantoine T; Dartigues JF; Cuffi MN; Bordes S; Gasnier Y; Robert P; Bories L; Rouaud O; Desclaux F; Sudres K; Bonnefoy M; Pesce A; Dufouil C; Lehericy S; Chupin M; Mangin JF; Payoux P; Adel D; Legrand P; Catheline D; Kanony C; Zaim M; Molinier L; Costa N; Delrieu J; Voisin T; Faisant C; Lala F; Nourhashémi F; Rolland Y; Van Kan GA; Dupuy C; Cantet C; Cestac P; Belleville S; Willis S; Cesari M; Weiner MW; Soto ME; Ousset PJ; Andrieu S
    J Prev Alzheimers Dis; 2014 Jun; 1(1):13-22. PubMed ID: 26594639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease.
    Gillette-Guyonnet S; Andrieu S; Dantoine T; Dartigues JF; Touchon J; Vellas B;
    Alzheimers Dement; 2009 Mar; 5(2):114-21. PubMed ID: 19328438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial.
    Bischoff-Ferrari HA; Vellas B; Rizzoli R; Kressig RW; da Silva JAP; Blauth M; Felson DT; McCloskey EV; Watzl B; Hofbauer LC; Felsenberg D; Willett WC; Dawson-Hughes B; Manson JE; Siebert U; Theiler R; Staehelin HB; de Godoi Rezende Costa Molino C; Chocano-Bedoya PO; Abderhalden LA; Egli A; Kanis JA; Orav EJ;
    JAMA; 2020 Nov; 324(18):1855-1868. PubMed ID: 33170239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
    Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
    JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?
    Coley N; Raman R; Donohue MC; Aisen PS; Vellas B; Andrieu S
    J Nutr Health Aging; 2018; 22(8):982-998. PubMed ID: 30272103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index.
    Hooper C; De Souto Barreto P; Coley N; Cantet C; Cesari M; Andrieu S; Vellas B
    J Nutr Health Aging; 2017; 21(9):988-993. PubMed ID: 29083439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.